Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5083499
Max Phase: Preclinical
Molecular Formula: C21H14ClF3N2O3
Molecular Weight: 434.80
Molecule Type: Unknown
Associated Items:
ID: ALA5083499
Max Phase: Preclinical
Molecular Formula: C21H14ClF3N2O3
Molecular Weight: 434.80
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc2c(c1)Oc1cc(Cl)ccc1C2NC(=O)c1ccc(C(F)(F)F)[nH]c1=O
Standard InChI: InChI=1S/C21H14ClF3N2O3/c1-10-2-4-12-15(8-10)30-16-9-11(22)3-5-13(16)18(12)27-20(29)14-6-7-17(21(23,24)25)26-19(14)28/h2-9,18H,1H3,(H,26,28)(H,27,29)
Standard InChI Key: MEDATINUJABWMR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 434.80 | Molecular Weight (Monoisotopic): 434.0645 | AlogP: 4.98 | #Rotatable Bonds: 2 |
Polar Surface Area: 71.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.38 | CX Basic pKa: | CX LogP: 3.97 | CX LogD: 3.97 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.60 | Np Likeness Score: -0.93 |
1. (2021) Modulators of hsd17b13 and methods of use thereof, |
Source(1):